IL-22 has been demonstrated to protect against inflammation at mucosal sites including the lung.3 To test whether IL-22 protects against ALI, we administered recombinant IL-22 intratracheally into mice immediately before LPS challenge. The gene discussed is IL22; the disease is acute respiratory distress syndrome.